Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo

Yellow fever virus (YFV) infection is a major public concern that threatens a large population in South America and Africa. No specific anti-YFV drugs are available till now. Here, we report that rifapentine is a potent YFV inhibitor in various cell lines by high-throughput drugs screening, acting a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xijing, Wu, Bingan, Tang, Hailin, Luo, Zhenghan, Xu, Zhenghao, Ouyang, Songying, Li, Xiangliang, Xie, Jianfeng, Yi, Zhigang, Leng, Qibin, Liu, Yan, Qi, Zhongtian, Zhao, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Antimicrobial Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942558/
https://www.ncbi.nlm.nih.gov/pubmed/35249454
http://dx.doi.org/10.1080/22221751.2022.2049983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942558/
https://www.ncbi.nlm.nih.gov/pubmed/35249454
http://dx.doi.org/10.1080/22221751.2022.2049983

Ejemplares similares